Back
Xeris Biopharma Holdings Vs. Exicure Industry Stock Comparison
Buy
95
XERS
Xeris Biopharma Holdings
Last Price:
3.44
Seasonality Move:
5.57%
Buy
62
XCUR
Exicure
Last Price:
30.86
Seasonality Move:
-4.03%
Buy
95
Xeris Biopharma Holdings (XERS)
is a Buy
Is Xeris Biopharma Holdings a Buy, Sell or Hold?
- The current Xeris Biopharma Holdings [XERS] share price is $3.45. The Score for XERS is 95, which is 90% above its historic median score of 50, and infers lower risk than normal.
- XERS is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
62
Exicure (XCUR)
is a Buy
Is Exicure a Buy, Sell or Hold?
- The current Exicure [XCUR] share price is $31.99. The Score for XCUR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- XCUR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XERS Stock Price Chart
What is Xeris Biopharma Holdings's stock price today?
-
The Xeris Biopharma Holdings share price today is $3.45
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XERS is experiencing buying pressure, which is a positive indicator for future bullish movement.
XCUR Stock Price Chart
XERS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 66.83 | Buy |
| Chaikin Money Flow: | 1457036 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.04 - 3.32) | Buy |
| Bollinger Bands (100): | (2.51 - 3.13) | Buy |
XCUR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.9 | Buy |
| Relative Strength Index (14 RSI): | 95.88 | Buy |
| Chaikin Money Flow: | 80777 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (-1.39 - 16.11) | Buy |
| Bollinger Bands (100): | (-1.28 - 8.54) | Buy |
XERS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.1 | Buy |
| 20-day SMA: | 3.17 | Buy |
| 50-day SMA: | 3.05 | Buy |
| 200-day SMA: | 2.51 | Buy |
| 8-day EMA: | 3.17 | Buy |
| 20-day EMA: | 3.14 | Buy |
| 50-day EMA: | 3.04 | Buy |
| 200-day EMA: | 2.62 | Buy |
XCUR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.08 | Buy |
| 20-day SMA: | 8.58 | Buy |
| 50-day SMA: | 5.2 | Buy |
| 200-day SMA: | 3.1 | Buy |
| 8-day EMA: | 19.83 | Buy |
| 20-day EMA: | 11.91 | Buy |
| 50-day EMA: | 6.88 | Buy |
| 200-day EMA: | 3.97 | Buy |
Xeris Biopharma Holdings Earnings Growth & XERS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.05 per share.
Exicure Earnings Growth & XCUR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Xeris Biopharma Holdings Technical Analysis
| Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Exicure Technical Analysis
| Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||